Novartis Market Capitalization

NVS -- USA Stock  

USD 84.44  0.53  0.63%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Novartis Market Capitalization Analysis

Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
Shares Outstanding 
Share Price 
More About Market Capitalization | All Equity Analysis
Novartis Market Capitalization  =
Novartis ValuationFundamentalsBuy or Sell

Market Capitalization Over Time Pattern

 Novartis Market Capitalization 

About Market Capitalization

In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Compare to competition
Consolidated Income
Based on recorded statements the market capitalization of Novartis AG is about 193.54B. This is 1395.5% higher than that of the Healthcare sector, and 6.99% higher than that of Drug Manufacturers - Major industry, The Market Capitalization for all stocks is 917.06% lower than the firm.

Novartis Market Capitalization Peer Comparison

  Market Capitalization 
      Novartis Comparables 
Novartis is regarded fourth in market capitalization category among related companies.

Novartis current financial ratios